At G.S.K, we believe that prevention is the best medicine. Prevention is pioneering new medicines to reduce

HIV transmission, applying decades of experience and asthma control to limit long-term lung damage or stopping chronic

conditions from progressing to more serious complications because preventing

disease is the best possible outcome for all of us and is why G.S.K. unite science, technology and talent to get ahead of

disease together. Visit gsk.com to learn more.

Behind the Knife, the surgery podcast, where we take a behind the scenes intimate look at surgery

from leaders in the field.

Welcome to another episode of Behind the Knife. We are continuing our landmark series with

SSO ASL and today we are going to discuss the paper,

randomized control trials examining

perioperative chemotherapy and post-operative adjuative

chemotherapy for receptable colorell liver metastases.

This is our continuation in discussing

the colorectal papers as our last paper alluded to talking about the

management of lateral lymph nodes.

This paper is going to be talking about yet another very

commonly occurring scenario in surgical oncology is colorectal liver

metastases.

And who better to discuss the topic

than the author of this landmark series

and an expert in this field, Dr. Jean Poet. He's the chair of the HPP section at MD Anderson. He did

his medical school as well as surgical training at Lausanne in Switzerland, and moved to the States in 2000. He has been at MD

...